Jing Tang has been awarded one of the prestigious ERC Starting Grants by the European Research Council. Tang’s project utilises computational systems medicine approaches, and aims to develop new ways to identify personalised drug combinations that are more effective against cancer.
Despite the great progress in cancer research in recent years, the clinical treatment of cancer patients is still challenged by the great molecular variability between patients with seemingly similar cancers.
Jing Tang, from the Institute for Molecular Medicine Finland (FIMM), is tackling this problem with data integration approaches. He is developing mathematical and computational tools, and is applying them to the rational selection of cancer drug combinations that can be used to provide personalised and more effective therapeutic strategies.
Read more on the University of Helsinki website.